Skip to main content
Have a personal or library account? Click to login
Investigating the Possibility to Individualize Asthma Attack Therapy Based on Attack Severity and Patient Characteristics Cover

Investigating the Possibility to Individualize Asthma Attack Therapy Based on Attack Severity and Patient Characteristics

Open Access
|Feb 2016

References

  1. 1. Usmani OS, Biddiscombe MF, Nightingale JA, Underwood SR, Barnes PJ. Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J Appl Physiol. 2003;95:2106-2112.
  2. 2. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of withinsubject responses to fluticasone and montelukast in childhood asthma. J Allergy ClinImmunol. 2005;115:233-242.
  3. 3. Fischer A, Stegemann J, Scheuch G, Siekmeier R. Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials. Eur J Med Res. 2009;14(Suppl. IV):71-77.
  4. 4. Haughney J, Price D, Kaplan A, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med. 2008;102:1681-93.
  5. 5. Kotses H, Stout C, McConnaughy K, Winder JA, Creer TL. Evaluation of individualized asthma self-management programs. J Asthma. 1996;33(2):113-8.
  6. 6. Fingleton J, Beasley R. Individualized treatment for asthma. Advances in Asthma Management. 2012;156-166.
  7. 7. Tantisira KG et al. Genomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma. N Engl J Med. 2011;365:1173-1183.
  8. 8. Portelli M, Sayers I. Genetic basis for personalized medicine in asthma. Expert Rev Respir Med. 2012;6(2):223-36.doi:10.1586/ers.12.9.
  9. 9. Poon AH, Hamid Q. Asthma Endotypes: The Right Direction Towards Personalized Medicine for Asthma. Expert Rev Clin Immunol. 2012;8(7):595-596.
  10. 10. Fajt ML, Wenzel SE. Biologic therapy in asthma: entering the new age of personalized medicine. J Asthma. 2014;51(7):669-76.
  11. 11. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135(2):299-310.
  12. 12. Darveaux J, Busse WW. Biologics in Asthma - The Next Step Toward Personalized Treatment. The Journal of Allergy and Clinical Immunology: In Practice. 2015;3(2):152-160.
  13. 13. Sárkány Z, Horváth A, Balásházy I, Hofmann W, Brînzaniuc K, Sabău M. Evaluation of inhaled drug deposition during an asthma attack using a stochastic lung model. Acta Medica Transilvanica. 2013;2(1):238-240.
  14. 14. Sárkány Z. Maximizing the amount of deposited particles during a severe asthma attack using the stochastic lung model. Acta Medica Marisiensis 2015;61(3):157-160.doi:10.1515/amma-2015-0043.
  15. 15. Stocks J, Quanjer PhH. Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J. 1995;8:492-506.
  16. 16. Martonen TB, Fleming J, Schroeter J, Conway J, Hwang D. In silico modelling of asthma. Advanced. Drug Delivery Reviews. 2003;55:829-849.
  17. 17. Chalupa DC, Morrow PE, Oberdorster G, Utell MJ, Frampton MW. Ultrafine particle deposition in subjects with asthma. Environmental Health Perspectives. 2004;112:879-882.
  18. 18. Longest PW, Vinchurkar S, Martonen T. Transport and deposition of respiratory aerosols in models of childhood asthma. Journal of Aerosol Science. 2006;37:1234-1257.
  19. 19. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006 Sep;130(3):827-33.
DOI: https://doi.org/10.1515/amma-2015-0120 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Language: English
Page range: 73 - 77
Submitted on: Sep 11, 2015
Accepted on: Nov 2, 2015
Published on: Feb 9, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Zoltán Sárkány, Kinga Sárkány, A. Horváth, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.